The American Journal of Medicine
Volume 123, Issue 1 , Pages 79-86 , January 2010

Subjective Symptoms after Treatment of Early Lyme Disease

  • Daša Cerar, MD

      Affiliations

    • Department of Infectious Diseases, University Medical Center Ljubljana, Slovenia
    • Corresponding Author InformationReprint requests should be addressed to Daša Cerar, MD, Japljeva 2, 1525 Ljubljana, Slovenia
    • ,
  • Tjaša Cerar, MicrobiolD, PhD

      Affiliations

    • Institute of Microbiology and Immunology, Medical Faculty, University of Ljubljana, Slovenia
    • ,
  • Eva Ružić-Sabljić, MD, PhD

      Affiliations

    • Institute of Microbiology and Immunology, Medical Faculty, University of Ljubljana, Slovenia
    • ,
  • Gary P. Wormser, MD

      Affiliations

    • Division of Infectious Diseases, Department of Medicine, New York Medical College, Valhalla
    • ,
  • Franc Strle, MD, PhD

      Affiliations

    • Department of Infectious Diseases, University Medical Center Ljubljana, Slovenia

References 

  1. Steere AC, Bartenhagen NH, Craft JE, et al. Clinical manifestations of Lyme disease. Zentral Bakteriol Mikrobiol Hyg. 1986;263:201–205
  2. Steere AC. Lyme disease. N Engl J Med. 2001;345:115–125
  3. Stanek G, Strle F. Lyme borreliosis. Lancet. 2003;362:1639–1647
  4. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089–1134
  5. Cairns V, Godwin J. Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. Int J Epidemiol. 2005;34:1340–1345
  6. Shapiro ED, Dattwyler R, Nadelman RB, Wormser GP. Response to meta-analysis of Lyme borreliosis symptoms. Int J Epidemiol. 2005;34:1437–1439
  7. Steere AC, Hutchinson GJ, Rahn DW, et al. Treatment of the early manifestations of Lyme disease. Ann Intern Med. 1983;99:22–26
  8. Luger SW, Paparone P, Wormser GP, et al. Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans. Antimicrob Agents Chemother. 1995;39:661–667
  9. Nadelman RB, Luger SW, Frank E, et al. Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease. Ann Intern Med. 1992;117:273–280
  10. Dattwyler RJ, Volkman DJ, Conaty SM, et al. Amoxicillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis. Lancet. 1990;336:1404–1406
  11. Massarotti EM, Luger SW, Rahn DW, et al. Treatment of early Lyme disease. Am J Med. 1992;92:396–403
  12. Wormser GP, Ramanathan R, Nowakowski J, et al. Duration of antibiotic therapy for early Lyme disease. Ann Intern Med. 2003;138:697–704
  13. Dattwyler RJ, Luft BJ, Kunkel MJ, et al. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N Engl J Med. 1997;337:289–294
  14. Luft BJ, Dattwyler RJ, Johnson RC, et al. Azithromycin compared with amoxicillin in the treatment of erythema migrans. Ann Intern Med. 1996;124:785–791
  15. Strle F, Ruzic E, Cimperman J. Erythema migrans: comparison of treatment with azithromycin, doxycycline and phenoxymethylpenicillin. J Antimicrobial Chemother. 1992;30:543–550
  16. Weber K, Wilske B, Preac-Mursic V, Thurmayr R. Azithromycin versus penicillin V for the treatment of early Lyme borreliosis. Infection. 1993;21:367–372
  17. Strle F, Preac-Mursic J, Cimperman J, et al. Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings. Infection. 1993;21:83–88
  18. Breier F, Kunz G, Klade H, et al. Erythema migrans: three weeks treatment for prevention of late Lyme borreliosis. Infection. 1996;24:69–72
  19. Barsic B, Maretic T, Majerus L, Strugar J. Comparison of azithromycin and doxycycline in the treatment of erythema migrans. Infection. 2000;28:153–156
  20. Feder HM, Johnson BJB, O'Connell S Ad Hoc International Lyme Disease Group. A critical appraisal of “chronic Lyme disease.”. N Engl J Med. 2007;357:1422–1430
  21. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance: Lyme disease (revised 9/96). MMWR Morb Mortal Wkly Rep. 1997;46:20–21
  22. Preac-Mursic V, Wilske B, Schierz G. European Borrelia burgdorferi isolated from humans and ticks (Culture conditions and antibiotic susceptibility). Zentral Bakteriol Mikrobiol Hyg. 1986;263:112–118
  23. Ruzić-Sabljić E, Strle F, Cimperman J, et al. Characterisation of Borrelia burgdorferi sensu lato strains isolated from patients with skin manifestations of Lyme borreliosis residing in Slovenia. J Med Microbiol. 2000;49:47–53
  24. Ruzić-Sabljić E, Maraspin V, Lotric-Furlan S, et al. Characterization of Borrelia burgdorferi sensu lato strains isolated from human material in Slovenia. Wien Klin Wochenschr. 2002;114:544–550
  25. Wormser GP, Liveris D, Nowakowski J, et al. Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease. J Infect Dis. 1999;180:720–725
  26. Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001;345:85–92
  27. Krupp LB, Hyman LG, Grimson R, et al. Study and treatment of post Lyme disease (Stop-LD) (A randomized double-masked clinical trial). Neurology. 2003;60:1923–1930
  28. Cluff LE. Medical aspects of delayed convalescence. Rev Infect Dis. 1991;13:S138–S140
  29. Nowakowski J, Nadelman RB, Sell R, et al. Long-term follow-up of patients with culture-confirmed Lyme disease. Am J Med. 2003;115:91–96
  30. Strle F, Nadelman RB, Cimperman J, et al. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med. 1999;130:32–36
  31. Carlsson SA, Granlund H, Jansson C, et al. Characteristics of erythema migrans in Borrelia afzelii and Borrelia garinii infections. Scand J Infect Dis. 2003;35:31–33
  32. Logar M, Ruzić-Sabljić E, Maraspin V, et al. Comparison of erythema migrans caused by Borrelia afzelii and Borrelia garinii. Infection. 2004;32:15–19
  33. Dinerman H, Steere AC. Lyme disease associated with fibromyalgia. Ann Intern Med. 1992;117:281–285

 Funding: Slovenian Research Agency.

 Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this manuscript.

 Authorship: All authors had access to the data and played a role in writing this manuscript.

PII: S0002-9343(09)00502-6

doi: 10.1016/j.amjmed.2009.05.011

The American Journal of Medicine
Volume 123, Issue 1 , Pages 79-86 , January 2010

Article Tools

* Image Usage & Resolution